Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barré syndrome

Autor(es): Taheraghdam Aliakbar,Pourkhanjar Peyman,Talebi Mahnaz,Bonyadi Mohammadreza,Pashapour Ali,Sharifipour Ehsan,Rikhtegar Reza

Resumo: Due to underlying autoimmune background of Guillain-Barré syndrome (GBS), the possible role of infectious agents cytomegalovirus (CMV) and Epstein-Barr virus (EBV) and also due to association of anti-ganglioside antibodies with GBS, the present study aimed to investigate the associations between serum anti-ganglioside antibodies (AGA) level, type of infection and electrodiagnostic (ED) findings with the severity and three-month functional outcome of patients with GBS. In a prospective study, 30 patients with GBS were selected and before starting the treatment, baseline serum samples of patients were obtained for measuring the serum AGA including the antibodies against GQ1b, GT1b, GD1a, GD1b, GM1, GM2, GM3 and strains of CMV and EBV. All the patients were precisely examined for ED findings. Functional status of patients on admission and three months after admission were recorded according to the modified Rankin scale (mRS). The results of patients' serum assessment revealed that CMV IgM was positive in one patient (3.3%), CMV IgG in 29 patients (96.7%) and EBV IgG in 27 patients (90%). Anti-GM1 was found in 3 patients (10%) and anti-GM3 was found only in one patient (3.3%). However, no statistical significant association was found between the AGA and strain of the disease and ED findings. Despite the coexistence of AGA and serum antibodies against CMV and EBV in some GBS patients, there was not clear association in this regard. However, the AGA was positive in patients who suffered from severe phase of the disease.

Palavras-Chave: Anti-Ganglioside Antibodies; Cytomegalovirus; Electrodiagnostic Findings; Epstein-Barr Virus; Guillain-Barré Syndrome

Imprenta: Iranian Journal of Neurology, v. 13, n. 1, p. 7-12, 2014

Descritores: Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Virus

Data de publicação: 2014